74 related articles for article (PubMed ID: 9709922)
1. Alterations of the MEN1 gene in sporadic parathyroid tumors.
Farnebo F; Teh BT; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson NW; Höög A; Weber G; Farnebo LO; Larsson C
J Clin Endocrinol Metab; 1998 Aug; 83(8):2627-30. PubMed ID: 9709922
[TBL] [Abstract][Full Text] [Related]
2. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
3. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.
Anlauf M; Perren A; Henopp T; Rudolf T; Garbrecht N; Schmitt A; Raffel A; Gimm O; Weihe E; Knoefel WT; Dralle H; Heitz PU; Komminoth P; Klöppel G
Gut; 2007 May; 56(5):637-44. PubMed ID: 17135306
[TBL] [Abstract][Full Text] [Related]
4. Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality.
Shan L; Nakamura Y; Murakami M; Nakamura M; Naito A; Kawahara K; Utsunomiya H; Mori I; Kakudo K
Jpn J Cancer Res; 1999 Sep; 90(9):965-9. PubMed ID: 10551325
[TBL] [Abstract][Full Text] [Related]
5. Germline and somatic genetic changes in multicentric tumors obtained from a patient with multiple endocrine neoplasia type 1.
Naruoka A; Ohnami S; Nagashima T; Serizawa M; Ohshima K; Ohnami S; Urakami K; Horiuchi Y; Kiyozumi Y; Abe M; Nakajima T; Sugiura T; Uesaka K; Kusuhara M; Yamaguchi K
Hum Genome Var; 2017; 4():17013. PubMed ID: 28503312
[TBL] [Abstract][Full Text] [Related]
6. The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
Storan D; Almeamar H; Flynn S; Sherlock M; Colombie M; Skehan SJ; Crowley RK
Eur J Endocrinol; 2024 May; ():. PubMed ID: 38781437
[No Abstract] [Full Text] [Related]
7. Reply to: The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
Kostiainen I; Schildt J; Parviainen H; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2024 Jun; ():. PubMed ID: 38828659
[No Abstract] [Full Text] [Related]
8. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
[TBL] [Abstract][Full Text] [Related]
9. First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome.
Chiloiro S; Capoluongo ED; Schinzari G; Concolino P; Rossi E; Martini M; Cocomazzi A; Grande G; Milardi D; Maiorano BA; Giampietro A; Rindi G; Pontecorvi A; De Marinis L; Bianchi A
Front Endocrinol (Lausanne); 2019; 10():365. PubMed ID: 31249555
[No Abstract] [Full Text] [Related]
10. Comparative Gene Expression Profiles in Parathyroid Adenoma and Normal Parathyroid Tissue.
Chai YJ; Chae H; Kim K; Lee H; Choi S; Lee KE; Kim SW
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30832348
[TBL] [Abstract][Full Text] [Related]
11. Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.
Khatami F; Tavangar SM
Biomark Insights; 2018; 13():1177271918785129. PubMed ID: 30013307
[TBL] [Abstract][Full Text] [Related]
12. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
Arnold A
Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism.
Bilezikian JP; Cusano NE; Khan AA; Liu JM; Marcocci C; Bandeira F
Nat Rev Dis Primers; 2016 May; 2():16033. PubMed ID: 27194212
[TBL] [Abstract][Full Text] [Related]
14. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
Yuan Z; Sánchez Claros C; Suzuki M; Maggi EC; Kaner JD; Kinstlinger N; Gorecka J; Quinn TJ; Geha R; Corn A; Pastoriza J; Jing Q; Adem A; Wu H; Alemu G; Du YC; Zheng D; Greally JM; Libutti SK
Oncotarget; 2016 Mar; 7(11):12633-50. PubMed ID: 26871472
[TBL] [Abstract][Full Text] [Related]
15. Recurrent ZFX mutations in human sporadic parathyroid adenomas.
Soong CP; Arnold A
Oncoscience; 2014; 1(5):360-6. PubMed ID: 25594030
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1 associated with breast cancer: A case report and review of the literature.
Jeong YJ; Oh HK; Bong JG
Oncol Lett; 2014 Jul; 8(1):230-234. PubMed ID: 24959251
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Costa-Guda J; Arnold A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T
Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020
[TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of large parathyroid adenomas.
Sulaiman L; Nilsson IL; Juhlin CC; Haglund F; Höög A; Larsson C; Hashemi J
Endocr Relat Cancer; 2012 Jun; 19(3):389-407. PubMed ID: 22454399
[TBL] [Abstract][Full Text] [Related]
20. The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.
Zhang JH; Seigneur EM; Pandey M; Loshakov A; Dagur PK; Connelly PS; Koo L; Panicker LM; Simonds WF
Cell Death Dis; 2012 Feb; 3(2):266. PubMed ID: 22297294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
